drugset / Trial / NCT01522196
A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to determine the effectiveness of A 001 infusion in preventing acute chest syndrome in sickle cell disease (SCD) subjects with vaso-occlusive crisis, fever, and elevated serum C-reactive protein (CRP).
Timeline
- Start
- 2012-02
- Primary completion
- 2012-03
- Completion
- 2012-03
Outcome
Outcome not reported
Stopped: “change in company plans”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Varespladib | Small molecule | 110 ug/kg | Intravenous |